Comparison of stroke risk factors and outcomes in patients with english-speaking background versus non-English-speaking background

Neuroepidemiology

Volumn 24, Issue 1-2, 2005, Pages 79-86

  Shen, Qing ^a,b   Cordato, Dennis J ^a,b   Chan, Daniel K Y ^a,b   Kokkinos, James ^a  

^a BANKSTOWN LIDCOMBE HOSPITAL   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Atrial fibrillation; Elderly; Ethnicity; Patient outcomes; Risk factors; Stroke

Indexed keywords

WARFARIN;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; DEMOGRAPHY; DIABETES MELLITUS; DRINKING BEHAVIOR; DRUG USE; DRUG UTILIZATION; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; HYPERTENSION; LANGUAGE; LIPID METABOLISM; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; RISK FACTOR; SMOKING; STROKE;

AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; AUSTRALIA; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; CEREBROVASCULAR ACCIDENT; DIABETES MELLITUS; EDUCATION; ETHNIC GROUPS; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTENSION; LANGUAGE; MALE; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; RISK FACTORS; SMOKING; TREATMENT OUTCOME;

EID: 10844285397     PISSN: 02515350     EISSN: None     Source Type: Journal    
DOI: 10.1159/000081054     Document Type: Article

References (22)

1. Australia's Health: Australian Institute of Health and Welfare, Canberra. Canberra, Australian Institute of Health and Welfare, 2000.
2. Wolf PA, Kannel WB, Verter J: Current status of risk factors for stroke. Neurol Clin 1983;1:317-343.
3. Sacco RL: Newer risk factors for stroke. Neurology 2001;57(suppl 2):S31-S34.
4. Manchev IC, Mineva PP, Hadjiev DI: Prevalence of stroke risk factors and their outcomes. Cerebrovasc Dis 2001;12:303-307.
5. Elkind MS, Sacco RL: Stroke risk factors and stroke prevention. Semin Neurol 1998;18:429-440.
6. Hart RG: Atrial fibrillation and stroke prevention. N Engl J Med 2003;349:1015-1016.
7. Fagerberg B, Claesson L, Gosman-Hedstrom G, et al: Effect of acute stroke unit care integrated with care continuum versus conventional treatment: A randomized 1-year study of elderly patients. The Goteborg 70+ stroke study. Stroke 2000;31:2578-2584.
8. Australian Bureau of Statistics: 2001 Census Usual Residents Profile, LGA 10350 Bankstown (C) (Local Government Area), Australia, New South Wales. http://www.abs.gov.au/.
9. Dodds T, Martin D, Stolov W, et al: A validation of the functional independence measurement and its performance among rehabilitation inpatients. Arch Phys Med Rehabil 1993;74:531-536.
10. Wolf PA, Abbott RD, Kannel WB: Atrial fibrillation as an independent risk factor for stroke: The Framingham Study. Stroke 1991;22:983-988.
11. Wolf PA, Abbott RD, Kannel WB: Atrial fibrillation: A major contributor to stroke in the elderly. The Framingham Study. Arch Intern Med 1987;147:1561-1564.
12. Wolf PA, Dawber TR, Thomas HE Jr, et al: Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: The Framingham study. Neurology 1978;28:973-977.
13. Feinberg WM, Blackshear JL, Laupacis A, et al: Prevalence, age distribution, and gender of patients with atrial fibrillation: Analysis and implications. Arch Intern Med 1995;155:469-473.
14. 4 Carroll K, Majeed A: Comorbidity associated with atrial fibrillation: A general practice-based study. Br J Gen Pract 2001;51:884-886, 889-891.
15. Hart RG: Stroke prevention in atrial fibrillation. Curr Cardiol Rep 2000;2:51-55.
16. Hart RG, Benavente O, McBride R, et al: Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: A meta-analysis. Ann Intern Med 1999;131:492-501.
17. Feinberg WM: Anticoagulation for prevention of stroke. Neurology 1998;51(suppl 3):S20-S22.
18. Atrial Fibrillation Investigators: Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: Analysis of pooled data from five randomized controlled trials. Arch Intern Med 1994;154:1449-1457.
19. Ackermann RJ: Anticoagulant therapy in patients aged 80 years or more with atrial fibrillation: More caution is needed. Arch Fam Med 1997;6:105-110.
20. Flaker GC, McGowan DJ, Boechler M, et al: Underutilization of antithrombotic therapy in elderly rural patients with atrial fibrillation. Am Heart J 1999;137:307-312.
21. Frykman V, Beerman B, Ryden L, et al: Management of atrial fibrillation: Discrepancy between guideline recommendation and actual practice exposes patients to risk for complications. Eur Heart J 2001;22:1954-1959.
22. Weisbord S, Whittle J, Brooks R: Is warfarin really underused in patients with atrial fibrillation? J Gen Intern Med 2001;16:743-749.